KERX

Keryx Biopharmaceuticals, Inc. News Headlines

$14.79
*  
0.125
0.85%
Get KERX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading KERX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% - Tale of the Tape
9/8/2014 7:55:00 AM - Zacks.com


Friday's ETF Movers: XLU, XBI
9/5/2014 12:50:28 PM - BNK Invest


Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline
9/5/2014 11:36:50 AM - Benzinga


Interesting KERX Put And Call Options For October 18th
8/19/2014 12:52:02 PM - BNK Invest


Tracking Seth Klarman's Baupost Group Holdings - Q2 2014 Update
8/15/2014 8:05:00 AM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha


Keryx Should Move Substantially In The Next Two Months
7/30/2014 2:04:00 PM - Seeking Alpha


Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains
6/24/2014 8:00:00 AM - Seeking Alpha


Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation
5/29/2014 7:34:00 PM - Seeking Alpha


Keryx Ferric Citrate (Zerenex) Could Potentially Save Hemodialysis Patients $1B Annually
5/22/2014 1:24:00 PM - Seeking Alpha


Seth Klarman's Baupost: Investment Changes During The First Quarter
5/19/2014 11:40:00 AM - Seeking Alpha


Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update
5/15/2014 4:18:00 AM - Seeking Alpha


Keryx Biopharmaceuticals Breaks Below 200-Day Moving Average - Notable for KERX
5/8/2014 10:57:40 AM - BNK Invest


Sector Update: Healthcare Shares Mixed Pre-Market; Repligen's Earnings Nearly Double Estimates
5/8/2014 7:23:18 AM - MT Newswires


Sector Update: Healthcare
5/8/2014 7:22:57 AM - MT Newswires


Cytokinetics Binary Failure Provides Solid Buying Opportunity
5/1/2014 10:05:00 AM - Seeking Alpha


Keryx Biopharmaceuticals: Is The High Valuation Justified?
4/16/2014 10:45:00 AM - Seeking Alpha


High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued
4/1/2014 8:30:00 AM - Seeking Alpha


Today's Market: Deals, Mergers And Rumors Pushing These Names Higher
3/27/2014 11:13:00 AM - Seeking Alpha


Mid-Afternoon Market Update: Markets Turn Red as Dish Network Rises
3/26/2014 2:46:31 PM - Benzinga


Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis Shares Decline
3/26/2014 11:28:22 AM - Benzinga


Wider Q4 Loss at Keryx - Analyst Blog
3/13/2014 12:19:01 PM - Zacks.com


Ferric Citrate [Zerenex] For The Treatment Of Hyperphosphatemia: A New Use For An Old Compound
2/25/2014 8:48:00 AM - Seeking Alpha


Use Options For a Chance To Buy KERX at a 41% Discount
2/24/2014 11:52:39 AM - BNK Invest


Investors are betting against Keryx Biopharmaceuticals (KERX), Should You? - Tale of the Tape
1/30/2014 6:56:01 AM - Zacks.com